These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26682789)

  • 1. Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study.
    Zipes DP; Neuzil P; Theres H; Caraway D; Mann DL; Mannheimer C; Van Buren P; Linde C; Linderoth B; Kueffer F; Sarazin SA; DeJongste MJL;
    JACC Heart Fail; 2016 Feb; 4(2):129-136. PubMed ID: 26682789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic Spinal Cord Stimulation for Heart Failure as a Restorative Treatment (SCS HEART study): first-in-man experience.
    Tse HF; Turner S; Sanders P; Okuyama Y; Fujiu K; Cheung CW; Russo M; Green MDS; Yiu KH; Chen P; Shuto C; Lau EOY; Siu CW
    Heart Rhythm; 2015 Mar; 12(3):588-595. PubMed ID: 25500165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
    Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
    Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Spinal Cord Stimulation on Cardiac Sympathetic Nerve Activity in Patients with Heart Failure.
    Naar J; Jaye D; Linde C; Neužil P; Doškář P; Málek F; Braunschweig F; Lund LH; Mortensen L; Linderoth B; Lind G; Bone D; Scholte AJ; Kueffer F; Koehler J; Shahgaldi K; Lang O; Ståhlberg M
    Pacing Clin Electrophysiol; 2017 May; 40(5):504-513. PubMed ID: 28206674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience.
    Torre-Amione G; Alo K; Estep JD; Valderrabano M; Khalil N; Farazi TG; Rosenberg SP; Ness L; Gill J
    Eur J Heart Fail; 2014 Jul; 16(7):788-95. PubMed ID: 24961194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodelling of cardiac sympathetic re-innervation with thoracic spinal cord stimulation improves left ventricular function in a porcine model of heart failure.
    Liao SY; Liu Y; Zuo M; Zhang Y; Yue W; Au KW; Lai WH; Wu Y; Shuto C; Chen P; Siu CW; Schwartz PJ; Tse HF
    Europace; 2015 Dec; 17(12):1875-83. PubMed ID: 25767085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of spinal cord stimulation as an adjunctive therapy in heart failure: A systematic review.
    Ashrafpour S; Ashrafpour M
    Neurophysiol Clin; 2024 May; 54(3):102945. PubMed ID: 38422720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
    Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
    St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
    Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
    Weiner RB; Baggish AL; Chen-Tournoux A; Marshall JE; Gaggin HK; Bhardwaj A; Mohammed AA; Rehman SU; Barajas L; Barajas J; Gregory SA; Moore SA; Semigran MJ; Januzzi JL
    Eur J Heart Fail; 2013 Mar; 15(3):342-51. PubMed ID: 23132825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study.
    Hopper I; Gronda E; Hoppe UC; Rundqvist B; Marwick TH; Shetty S; Hayward C; Lambert T; Hering D; Esler M; Schlaich M; Walton A; Airoldi F; Brandt MC; Cohen SA; Reiters P; Krum H
    J Card Fail; 2017 Sep; 23(9):702-707. PubMed ID: 28645757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensor-driven position-adaptive spinal cord stimulation for chronic pain.
    Schultz DM; Webster L; Kosek P; Dar U; Tan Y; Sun M
    Pain Physician; 2012; 15(1):1-12. PubMed ID: 22270733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2014 Nov; 20(11):808-16. PubMed ID: 25187002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.